LGBTQ pedophile "Pride" event at North Hollywood elementary school draws protest, heightened security

[Biden pedophiles]

Thank Barack Obama for the queer confusion and absence of race
relations in the USA.

NORTH HOLLYWOOD, LOS ANGELES (KABC) -- Heightened security was in place at
Saticoy Elementary School in North Hollywood Friday as some protested a
Pride Month recognition at the campus, sparking complaints that the topic
is one that should be left for parents to teach rather than having it
imposed on kids at school.

Parents who are opposed to the Pride event created an Instagram account to
express displeasure with the move, calling for other parents to keep their
kids home from school on Friday in a form of protest against the planned
assembly.

The parents' message was on display before they even began gathering
Friday. At least two trailers were parked right across the school covered
in large signs that read "Leave our kids alone."

Crowds of protesters, as well as counter-protesters, started gathering
around 8 a.m. outside the school with Los Angeles police officers nearby.

The crowd remained mostly peaceful, but AIR7 HD was overhead when some
individuals appeared to get into a heated argument. No major issues were
reported.

Jack Satamian has two children at Saticoy. He's among the group of parents
planning to keep his children home on Friday, and believes children should
not be taught about "any kind of sexual preferences."

"I didn't bring them into this world for a teacher to explain to them what
is gay -- or what two men or two women do -- some certain things should be
left to the parents to decide whether they want their kids to be exposed
to it or not -- at least at a certain age."

Other parents like Erica Denesesn have no concerns.

"It's how the world is today and if you shield them from it, then it's
just going to make a bigger impact later... and it might be kinda
sideways. I think it's really great to expose them and just talk about
everybody," she said.

The concerns expressed by protesting parents has led to accusations of
bigotry and intolerance. The tensions intensified this week with news that
a small Pride flag that was on display outside a campus classroom was
burned sometime during the weekend of May 20-21.

It's not clear who burned it, but police are investigating the incident as
a possible hate crime.

Organizers of the parent protest have vehemently denied any involvement
with the flag-burning. They have also insisted that the protest is not
founded in intolerance or bigotry -- rather in the belief that parents
should have the right to decide when to discuss the topic of LGBTQ pride
with their children.

The organizers also posted repeated messages calling on protesters to be
peaceful, calm and respectful.

The Los Angeles Unified School District, however, indicated that security
will be beefed up around the campus Friday out of an abundance of caution.

In a statement to Eyewitness News, a spokesperson for the Los Angeles
Unified School District said, in part: "As part of our engagement with
school communities, our schools regularly discuss the diversity of the
families that we serve and the importance of inclusion. This remains an
active discussion with our school communities and we remain committed to
continuing to engage with families about this important topic. Families
are always encouraged to discuss important topics with their children and
families may also contact their schools for more information about any
school programs or activities."

https://abc7.com/lgbtq-pride-assembly-protest-parents-saticoy-elementary-
school/13332694/

[Klaus Schadenfreude]

[Default] On Sat, 3 Jun 2023 00:27:13 +0200 (CEST), Biden pedophiles

Post by Biden pedophiles
NORTH HOLLYWOOD, LOS ANGELES (KABC) -- Heightened security was in place at
Saticoy Elementary School in North Hollywood Friday as some protested a
Pride Month recognition at the campus, sparking complaints that the topic
is one that should be left for parents to teach rather than having it
imposed on kids at school.

100% correct. There's no reason for any of this shit at a public
school.

[Pelosi the queer enabler]

Never shake hands with or touch a queer. They are totally infested
with germs.

Diagnostic Considerations
Interpretation of treponemal and nontreponemal serologic tests for persons
with HIV infection is the same as for persons without HIV. Although rare,
unusual serologic responses have been observed among persons with HIV
infection who have syphilis. The majority of reports have involved
posttreatment serologic titers that were higher than expected (i.e., high
serofast) or fluctuated, and false-negative serologic test results and
delayed appearance of seroreactivity have also been reported (622).

When clinical findings are indicative of syphilis, but serologic tests are
nonreactive or their interpretation is unclear, alternative tests (e.g.,
biopsy of a lesion, darkfield examination, or PCR of lesion material)
might be useful for diagnosis. Neurosyphilis, ocular syphilis, and
otosyphilis should be considered in the differential diagnosis of
neurologic, ocular, and other signs and symptoms among persons with HIV
infection.

Treatment
Persons with HIV infection who have early syphilis might be at increased
risk for neurologic complications (623) and might have higher rates of
inadequate serologic response with recommended regimens. The magnitude of
these risks is not defined precisely but is likely small. Although long-
term (>1 year) comparative data are lacking, no treatment regimens for
syphilis have been demonstrated to be more effective in preventing
neurosyphilis among persons with HIV infection than the syphilis regimens
recommended for persons without HIV (609). Careful follow-up after therapy
is essential. Using ART per current HIV guidelines might improve clinical
outcomes among persons coinfected with HIV and syphilis; concerns
regarding adequate treatment of syphilis among persons with HIV infection
might not apply to those with HIV virologic suppression (624,625).

Primary and Secondary Syphilis Among Persons with HIV Infection
Recommended Regimen for Primary and Secondary Syphilis Among Persons with
HIV Infection
Benzathine penicillin G, 2.4 million units IM in a single dose

Available data demonstrate that additional doses of benzathine penicillin
G, amoxicillin, or other antibiotics in primary and secondary syphilis
among persons with HIV infection do not result in enhanced efficacy
(592,593,609).

Other Management Considerations
The majority of persons with HIV infection respond appropriately to the
recommended benzathine penicillin G treatment regimen for primary and
secondary syphilis (626). CSF abnormalities (e.g., mononuclear pleocytosis
and elevated protein levels) can be common among persons with HIV, even
those without syphilis. The clinical and prognostic significance of such
CSF laboratory abnormalities among persons with primary and secondary
syphilis who lack neurologic symptoms is unknown. Certain studies have
demonstrated that among persons with HIV infection and syphilis, CSF
abnormalities are associated with a CD4+ T-cell count of =350 cells/mL or
an RPR titer of =1:32 (614,627). However, CSF examination followed by
treatment for neurosyphilis on the basis of laboratory abnormalities has
not been associated with improved clinical outcomes in the absence of
neurologic signs and symptoms. All persons with HIV infection and primary
and secondary syphilis should have a thorough neurologic, ocular, and otic
examination (614,622,625). CSF examination should be reserved for those
with an abnormal neurologic examination.

Follow-Up
Persons with HIV infection and primary or secondary syphilis should be
evaluated clinically and serologically for possible treatment failure at
3, 6, 9, 12, and 24 months after therapy; those who meet the criteria for
treatment failure (i.e., signs or symptoms that persist or recur or a
sustained [>2 weeks] fourfold or greater increase in titer) should be
managed in the same manner as persons without HIV infection (i.e.,
depending on history of sexual activity and on findings of neurologic
examination, either repeat treatment with weekly injections of benzathine
penicillin G 2.4 million units IM for 3 weeks or CSF examination and
repeat treatment guided by CSF findings) (see Primary and Secondary
Syphilis).

In addition, CSF examination and retreatment can be considered for persons
whose nontreponemal test titers do not decrease fourfold within 24 months
of therapy. If CSF examination is normal, treatment with benzathine
penicillin G administered as 2.4 million units IM at weekly intervals for
3 weeks is recommended. Serologic titers might not decrease despite a
negative CSF examination and a repeated 3-week course of therapy (599).
Especially if the initial nontreponemal titer is low (<1:8) in these
circumstances, the benefit of additional therapy or repeated CSF
examinations is unclear but is not usually recommended. Serologic and
clinical monitoring at least annually should continue to monitor for any
sustained increases in nontreponemal titer.

Management of Sex Partners
See Syphilis, Management of Sex Partners.

https://www.cdc.gov/std/treatment-guidelines/syphilis-hiv.htm

[Pelosi the queer enabler]

They know they are sick and mentally ill.

Transgender persons often experience high rates of stigma and
socioeconomic and structural barriers to care that negatively affect
health care usage and increase susceptibility to HIV and STIs (326–332).
Persons who are transgender have a gender identity that differs from the
sex that they were assigned at birth (333,334). Transgender women (also
known as trans women, transfeminine persons, or women of transgender
experience) are women who were assigned male sex at birth (born with male
anatomy). Transgender men (also known as trans men, transmasculine
persons, or men of transgender experience) are men who were assigned
female sex at birth (i.e., born with female anatomy). In addition, certain
persons might identify outside the gender binary of male or female or move
back and forth between different gender identities and use such terms as
“gender nonbinary,” “genderqueer,” or “gender fluid” to describe
themselves. Persons who use terms such as “agender” or “null gender” do
not identify with having any gender. The term “cisgender” is used to
describe persons who identify with their assigned sex at birth. Prevalence
studies of transgender persons among the overall population have been
limited and often are based on small convenience samples.

Gender identity is independent of sexual orientation. Sexual orientation
identities among transgender persons are diverse. Persons who are
transgender or gender diverse might have sex with cisgender men, cisgender
women, or other transgender or gender nonbinary persons.

Clinical Environment Assessment
Providers should create welcoming environments that facilitate disclosure
of gender identity and sexual orientation. Clinics should document gender
identity and sex assigned at birth for all patients to improve sexual
health care for transgender and gender nonbinary persons. Assessment of
gender identity and sex assigned at birth has been validated among diverse
populations, has been reported to be acceptable (335,336), and might
result in increased patients identifying as transgender (337).

Lack of medical provider knowledge and other barriers to care (e.g.,
discrimination in health care settings or denial of services) often result
in transgender and gender nonbinary persons avoiding or delaying
preventive care services (338–340) and incurring missed opportunities for
HIV and STI prevention services. Gender-inclusive and trauma-guided health
care might increase the number of transgender patients who seek sexual
health services, including STI testing (341), because transgender persons
are at high risk for sexual violence (342).

Primary care providers should take a comprehensive sexual history,
including a discussion of STI screening, HIV PrEP and PEP, behavioral
health, and social determinants of sexual health. Clinicians can improve
the experience of sexual health screening and counseling for transgender
persons by asking for their choice of terminology or modifying language
(e.g., asking patients their gender pronouns) to be used during clinic
visits and history taking and examination (343). Options for fertility
preservation, pregnancy potential, and contraception options should also
be discussed, if indicated. For transgender persons who retain a uterus
and ovaries, ovulation might continue in the presence of testosterone
therapy, and pregnancy potential exists (https://transcare.ucsf.edu).

Transgender Women
Doxy-PEP as an STI Prevention Strategy: Considerations for individuals and
healthcare providers of gay or bisexual men or transgender women

A systematic review and meta-analysis of HIV infection among transgender
women estimated that HIV prevalence in the United States is 14% among
transgender women, with the highest prevalence among Black (44%) and
Hispanic (26%) transgender women (344). Data also demonstrate high rates
of HIV infection among transgender women worldwide (345). Bacterial STI
prevalence varies among transgender women and is based largely on
convenience samples. Despite limited data, international and U.S. studies
have indicated elevated incidence and prevalence of gonorrhea and
chlamydia among transgender women similar to rates among cisgender MSM
(346–348). A recent study using data from the STD Surveillance Network
revealed that the proportions of transgender women with extragenital
chlamydial or gonococcal infections were similar to those of cisgender MSM
(349).

https://www.cdc.gov/std/treatment-guidelines/trans.htm

[Pelosi the queer enabler]

Queers are mentally ill nut jobs.

Sexually transmitted gastrointestinal syndromes include proctitis,
proctocolitis, and enteritis. Evaluation for these syndromes should
include recommended diagnostic procedures, including anoscopy or
sigmoidoscopy, stool examination for WBCs, and microbiologic workup (e.g.,
gonorrhea, chlamydia [LGV PCR if available], herpes simplex NAAT, and
syphilis serology). For those with enteritis, stool culture or LGV PCR
also is recommended.

Proctitis is inflammation of the rectum (i.e., the distal 10–12 cm) that
can be associated with anorectal pain, tenesmus, or rectal discharge.
Fecal leukocytes are common. Proctitis occurs predominantly among persons
who have receptive anal exposures (oral-anal, digital-anal, or genital-
anal). N. gonorrhoeae, C. trachomatis (including LGV serovars), HSV, and
T. pallidum are the most common STI pathogens. Genital HSV and LGV
proctitis are more prevalent among persons with HIV infection
(545,556,1382). M. genitalium has been detected in certain cases of
proctitis and might be more common among persons with HIV infection
(937,1382). N. meningitidis has been identified as an etiology of
proctitis among MSM with HIV infection (1383).

Proctocolitis is associated with symptoms of proctitis, diarrhea or
abdominal cramps, and inflammation of the colonic mucosa extending to 12
cm above the anus. Fecal leukocytes might be detected on stool
examination, depending on the pathogen. Proctocolitis can be acquired
through receptive anal intercourse or by oral-anal contact, depending on
the pathogen.

Pathogenic organisms include Campylobacter species, Shigella species, E.
histolytica, LGV serovars of C. trachomatis, and T. pallidum. Among
immunosuppressed persons with HIV infection, CMV or other opportunistic
agents should be considered. The clinical presentation can be mistaken for
inflammatory bowel disease or malignancy, resulting in a delayed diagnosis
(1384,1385).

Enteritis usually results in diarrhea and abdominal cramping without signs
of proctitis or proctocolitis. Fecal leukocytes might be detected on stool
examination, depending on the pathogen. When outbreaks of gastrointestinal
illness occur among social or sexual networks of MSM, clinicians should
consider sexual transmission as a mode of spread and provide counseling
accordingly. Sexual practices that can facilitate transmission of enteric
pathogens include oral-anal contact or, in certain instances, direct
genital-anal contact. G. lamblia is the most frequently implicated
parasite, and bacterial pathogens include Shigella species, Salmonella, E.
coli, Campylobacter species, and Cryptosporidium. Outbreaks of Shigella
species, Campylobacter, Cryptosporidium, and microsporidiosis have been
reported among MSM (259,274,1386,1387). Multiple enteric pathogens and
concurrent STIs have also been reported. Among immunosuppressed persons
with HIV infection, CMV or other opportunistic pathogens should be
considered.

Diagnostic and Treatment Considerations for Acute Proctitis
Diagnosis
Persons with symptoms of acute proctitis should be examined by anoscopy. A
Gram-stained smear of any anorectal exudate from anoscopic or anal
examination should be examined for polymorphonuclear leukocytes. All
persons should be evaluated for herpes simplex (preferably by NAAT of
rectal lesions), N. gonorrhoeae (NAAT or culture), C. trachomatis (NAAT),
and T. pallidum (darkfield of lesion if available and serologic testing).
If the C. trachomatis NAAT test is positive on a rectal swab and severe
symptoms associated with LGV are present (including rectal ulcers, anal
discharge, bleeding, =10 WBCs on Gram stain, and tenesmus), patients
should be treated empirically for LGV. Molecular testing for LGV is not
widely available or not FDA cleared, and results are not typically
available in time for clinical decision-making. However, if available,
molecular PCR testing for C. trachomatis serovars L1, L2, or L3 can be
considered for confirming LGV (553).

The pathogenic role of M. genitalium in proctitis is unclear. For persons
with persistent symptoms after standard treatment, providers should
consider testing for M. genitalium with NAAT and treat if positive (see
Mycoplasma genitalium).

Treatment
Acute proctitis among persons who have anal exposure through oral,
genital, or digital contact is usually sexually acquired (1382,1388).
Presumptive therapy should be initiated while awaiting results of
laboratory tests for persons with anorectal exudate detected on
examination or polymorphonuclear leukocytes detected on a Gram-stained
smear of anorectal exudate or secretions. Such therapy also should be
initiated when anoscopy or Gram stain is not available and the clinical
presentation is consistent with acute proctitis for persons reporting
receptive anal exposures.

Recommended Regimen for Acute Proctitis
Ceftriaxone 500 mg* IM in a single dose

PLUS

Doxycycline 100 mg orally 2 times/day for 7 days†

* For persons weighing =150 kg, 1 g of ceftriaxone should be administered.

† Doxycycline course should be extended to 100 mg orally 2 times/day for
21 days in the presence of bloody discharge, perianal or mucosal ulcers,
or tenesmus and a positive rectal chlamydia test.

Bloody discharge, perianal ulcers, or mucosal ulcers among persons with
acute proctitis and rectal chlamydia (NAAT) should receive presumptive
treatment for LGV with an extended course of doxycycline 100 mg orally 2
times/day for 3 weeks (1389,1390) (see Lymphogranuloma Venereum). If
painful perianal ulcers are present or mucosal ulcers are detected on
anoscopy, presumptive therapy should also include a regimen for genital
herpes (see Genital Herpes).

Diagnostic and Treatment Considerations for Proctocolitis or Enteritis
Treatment for proctocolitis or enteritis should be directed to the
specific enteric pathogen identified. Multiple stool examinations might be
necessary for detecting Giardia, and special stool preparations are
required for diagnosing cryptosporidiosis and microsporidiosis. Diagnostic
and treatment recommendations for all enteric infections are beyond the
scope of these guidelines. Providers should be aware of the potential for
antimicrobial-resistant pathogens, particularly during outbreaks of
Shigella and Campylobacter among sexual networks of MSM where increased
resistance to azithromycin, fluoroquinolones, and isolates resistant to
multiple antibiotics have been described (266,272,273,1391,1392).

Other Management Considerations
To minimize transmission and reinfection, patients treated for acute
proctitis should be instructed to abstain from sexual intercourse until
they and their partners have been treated (i.e., until completion of a 7-
day regimen and symptoms have resolved). Studies have reported that
behaviors that facilitate enteric pathogen transmission might be
associated with acquisition of other STIs, including HIV infection. All
persons with acute proctitis and concern for sexually transmitted
proctocolitis or enteritis should be tested for HIV, syphilis, gonorrhea,
and chlamydia (at other exposed sites). PEP should be considered for
exposures that present a risk for HIV acquisition. For ongoing risk for
HIV acquisition, PrEP should be considered.

Evidence-based interventions for preventing acquisition of sexually
transmitted enteric pathogens are not available. However, extrapolating
from general infection control practices for communicable diseases and
established STI prevention practices, recommendations include avoiding
contact with feces during sex, using barriers, and washing hands after
handing materials that have been in contact with the anal area (i.e.,
barriers and sex toys) and after touching the anus or rectal area.

Follow-Up
Follow-up should be based on specific etiology and severity of clinical
symptoms. For proctitis associated with gonorrhea or chlamydia, retesting
for the respective pathogen should be performed 3 months after treatment.

Management of Sex Partners
Partners who have had sexual contact with persons treated for gonorrhea or
chlamydia <60 days before the onset of the persons symptoms should be
evaluated, tested, and presumptively treated for the respective infection.
Partners of persons with proctitis should be evaluated for any diseases
diagnosed in the index partner. Sex partners should abstain from sexual
contact until they and their partners are treated. No specific
recommendations are available for screening or treating sex partners of
persons with diagnosed sexually transmitted enteric pathogens; however,
partners should seek care if symptomatic.

Special Considerations
Drug Allergy, Intolerance, and Adverse Reactions
Allergic reactions with third-generation cephalosporins (e.g.,
ceftriaxone) are uncommon among persons with a history of penicillin
allergy (620,631,658,896).

HIV Infection
Persons with HIV infection and acute proctitis might present with bloody
discharge, painful perianal ulcers, or mucosal ulcers and LGV and herpes
proctitis are more prevalent among this population. Presumptive treatment
in such cases should include a regimen for genital herpes and LGV.'

https://www.cdc.gov/std/treatment-guidelines/proctitis.htm

[Pelosi the queer enabler]

Every stinking queer has some kind of incurable sexual disease.

Infection with HIV causes an acute but brief and nonspecific influenza-
like retroviral syndrome that can include fever, malaise, lymphadenopathy,
pharyngitis, arthritis, or skin rash. Most persons experience at least one
symptom; however, some might be asymptomatic or have no recognition of
illness (406–409). Acute infection transitions to a multiyear, chronic
illness that progressively depletes CD4+ T lymphocytes crucial for
maintenance of effective immune function. Ultimately, persons with
untreated HIV infection experience symptomatic, life-threatening
immunodeficiency (i.e., AIDS).

Effective ART that suppresses HIV replication to undetectable levels
reduces morbidity, provides a near-normal lifespan, and prevents sexual
transmission of HIV to others (95–97,410– 412). Early diagnosis of HIV and
rapid linkage to care are essential for achieving these goals. Guidelines
from both the U.S. Department of Health and Human Services and the
International AIDS Society–USA Panel recommend that all persons with HIV
infection be offered effective ART as soon as possible, both to reduce
morbidity and mortality and to prevent HIV transmission (413).

STD specialty or sexual health clinics are a vital partner in reducing HIV
infections in the United States. These clinics provide safety net services
to vulnerable populations in need of HIV prevention services who are not
served by the health care system and HIV partner service organizations.
Diagnosis of an STI is a biomarker for HIV acquisition, especially among
persons with primary or secondary syphilis or, among MSM, rectal gonorrhea
or chlamydia (197). STD clinics perform only approximately 20% of all
federally funded HIV tests nationally but identify approximately 30% of
all new infections (414). Among testing venues, STD clinics are high
performing in terms of linkage to HIV care within 90 days of diagnosis;
during 2013–2017, the percentage of persons with a new diagnosis in an STD
clinic and linked to care within 90 days increased from 55% to >90%
(415,415).

Screening Recommendations
The following recommendations apply to testing for HIV:

HIV testing is recommended for all persons seeking STI evaluation who are
not already known to have HIV infection. Testing should be routine at the
time of the STI evaluation, regardless of whether the patient reports any
specific behavioral risks for HIV. Testing for HIV should be performed at
the time of STI diagnosis and treatment if not performed at the initial
STI evaluation and screening (82,195,416).
CDC and USPSTF recommend HIV screening at least once for all persons aged
15–65 years (417).
Persons at higher risk for HIV acquisition, including sexually active gay,
bisexual, and other MSM, should be screened for HIV at least annually.
Providers can consider the benefits of offering more frequent screening
(e.g., every 3–6 months) among MSM at increased risk for acquiring HIV
(418,419).
All pregnant women should be tested for HIV during the first prenatal
visit. A second test during the third trimester, preferably at <36 weeks’
gestation, should be considered and is recommended for women who are at
high risk for acquiring HIV infection, women who receive health care in
jurisdictions with high rates of HIV, and women examined in clinical
settings in which HIV incidence is =1 per 1,000 women screened per year
(138,140).
HIV screening should be voluntary and free from coercion. Patients should
not be tested without their knowledge.
Opt-out HIV screening (notifying the patient that an HIV test will be
performed, unless the patient declines) is recommended in all health care
settings. CDC also recommends that consent for HIV screening be
incorporated into the general informed consent for medical care in the
same manner as other screening or diagnostic tests.
Requirement of specific signed consent for HIV testing is not recommended.
General informed consent for medical care is considered sufficient to
encompass informed consent for HIV testing.
Providers should use a laboratory-based antigen/antibody (Ag/Ab)
combination assay as the first test for HIV, unless persons are unlikely
to follow up with a provider to receive their HIV test results; in those
cases screening with a rapid POC test can be useful.
Preliminary positive screening tests for HIV should be followed by
supplemental testing to establish the diagnosis.
Providing prevention counseling as part of HIV screening programs or in
conjunction with HIV diagnostic testing is not required (6). However,
persons might be more likely to think about HIV and consider their risk-
related behavior when undergoing an HIV test. HIV testing gives providers
an opportunity to conduct STI and HIV prevention counseling and
communicate risk-reduction messages.
Acute HIV infection can occur among persons who report recent sexual or
needle-sharing behavior or who have had an STI diagnosis.
Providers should test for HIV RNA if initial testing according to the HIV
testing algorithm recommended by CDC is negative or indeterminate when
concerned about acute HIV infection
(https://stacks.cdc.gov/view/cdc/50872).
Providers should not assume that a laboratory report of a negative HIV
Ag/Ab or antibody test indicates that the requisite HIV RNA testing for
acute HIV infection has been conducted. They should consider explicitly
requesting HIV RNA testing when concerned about early acute HIV infection.
Providers should assess eligibility of all persons seeking STI services
for HIV PrEP and PEP. For persons with substantial risk whose results are
HIV negative, providers should offer or provide referral for PrEP
services, unless the last potential HIV exposure occurred <72 hours, in
which case PEP might be indicated.

https://www.cdc.gov/std/treatment-guidelines/hiv.htm

[Pelosi the queer enabler]

queers are sexually stimulated by the smell and taste of fecal matter.

Note: Content below contains mature language.

Gay, bisexual, and other men who have sex with men* are among groups at
high risk for infection with Shigella germs. This infection is called
shigellosis. Shigella germs spread easily and rapidly among people,
including during sexual activity.

Men who have sex with men are particularly at risk for infections with
antimicrobial-resistant Shigella. Antimicrobial resistance happens when
germs like bacteria and fungi develop the ability to defeat the drugs
designed to kill them. That means the germs are not killed and continue to
grow. Shigella germs are increasingly resistant to antibiotic treatment.

Shigella by the Numbers
CDC estimates that Shigella germs cause nearly 450,000 infections in the
United States each year. We do not know how many of these infections are
among men who have sex with men. However, multiple outbreaks of Shigella
among men who have sex with men have been reported worldwide.

Antimicrobial-Resistant Shigella

Infections with antimicrobial-resistant Shigella have been on the rise in
the United States since 2013. Most people with Shigella
infection—including those infected with antimicrobial-resistant
Shigella—recover within 5 to 6 days without antibiotics. However, some
people need antibiotics, including people who have a severe or long-
lasting infection or are at risk of one.

People at risk of a severe or long-lasting infection include those with a
weakened immune system due to certain medical conditions (such as
infection with HIV) or treatments (such as chemotherapy for cancer). These
people are also at increased risk for the infection spreading into the
blood, which can be life-threatening.

Shigella Germs Can Spread During Sexual Activity
Shigella germs pass from the poop (stool) or unclean fingers of one person
to the mouth of another person. This can happen during sexual activity
through:

Direct sexual contact: Anal or oral sex, or anal play (rimming, fingering)
Indirect sexual contact: Handling contaminated objects, such as sex toys,
used condoms or barriers, and douching materials
Symptoms typically start 1 to 2 days after swallowing the germs and
include diarrhea, fever, and abdominal pain. However, not everyone with
Shigella infection has symptoms.

Shigella germs can be found in the poop of people with diarrhea and can
continue to be found in their poop for up to two weeks after the diarrhea
has gone away.

Protect Yourself and Your Partner

Take steps to reduce oral contact with poop during sex:

Wash your hands, genitals, and anus with soap and water before and after
sexual activity. Wash hands, especially after touching sex toys, used
condoms or barriers, and douching materials.
Use barriers like condoms or dental dams during oral sex and oral-anal
sex.
Use condoms the right way, every time you have anal sex or oral sex.
Condoms will also help prevent other sexually transmitted diseases.
Use latex gloves during anal fingering or fisting.
Wash sex toys with soap and water after each use and wash hands after
touching used sex toys.
If you or your partner has been diagnosed with shigellosis, do not have
sex. To reduce the chance of Shigella germs spreading, wait at least two
weeks after diarrhea ends to have sex.

Talk with Your Doctor
Talk with your doctor if you think you might have Shigella infection
(shigellosis). Your doctor can test your poop to determine if you are sick
with shigellosis. They can also order an additional test at the same time
to check whether your type of infection is resistant to antibiotics.

If You’ve Been Diagnosed with Shigella infection (shigellosis)
If you’ve been diagnosed with Shigella infection (shigellosis), take the
following steps to prevent spreading it to others.

Wash hands often, especially:
Before eating or preparing food.
After using the bathroom.
Do NOT prepare food if you are sick or share food with anyone.
Do not swim.
Do NOT have sex for at least two weeks after you no longer have diarrhea.
Stay home from school or from healthcare, food service, or childcare jobs
while sick or until your health department says it’s safe to return.
More Information
Prevent Shigella Infection
Questions & Answers
Proctitis, Proctocolitis, and Enteritis – STI Treatment Guidelines
Travelers’ Health: Yellow Book-Shigellosis
Diarrhea and Swimming
*The term “men who have sex with men” is used in CDC surveillance systems
because it indicates men who engage in behaviors that may transmit
Shigella infection, rather than how someone identifies their sexuality.

https://www.cdc.gov/shigella/msm.html